Li Yi

Li Yi serves as the Executive Director of Biologics Pre-pivotal Formulation and Process Development at Gilead Sciences since February 2024. Prior to this role, Li Yi was at AbbVie from November 2019 to February 2024, where positions included Center Director and Director of Pharmaceutical Development. Li Yi's earlier experience at Genentech spanned from May 2009 to November 2019, including roles as Senior Scientist, Group Leader, and Manager. Responsibilities involved formulation development for late-stage clinical trials and commercialization, along with scientific research on chemical degradation in proteins. Li Yi began professional training as an Associate Scientist focusing on formulation development for early-phase clinical trials and served as a Postdoctoral Fellow at the University of Michigan earlier in 2009. Educational qualifications include a Ph.D. in Chemistry from the University of Michigan and a B.S. in Chemistry from Fudan University.